Back pain in adolescents: Assessment with integrated 18F-fluoride positron-emission tomography-computed tomography

Journal of Pediatric Orthopaedics

Volumn 27, Issue 1, 2007, Pages 90-93

  Ovadia, Dror ^a,b   Metser, Ur ^a   Lievshitz, Gennady ^a   Yaniv, Moshe ^a   Wientroub, Shlomo ^a   Even Sapir, Einat ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Adolescence; Back pain; Computed tomography; Fluorodeoxyglucose F18; Imaging studies

Indexed keywords

ANALGESIC AGENT; FATTY ACID; FLUORINE 18; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BACKACHE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE DURATION; DRUG UPTAKE; FEMALE; FRACTURE; FUNCTIONAL ASSESSMENT; HUMAN; IMAGING; INTERVERTEBRAL DISK HERNIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; OSTEOID OSTEOMA; PATHOLOGICAL ANATOMY; PATIENT POSITIONING; PHYSICAL DISABILITY; PRIORITY JOURNAL; PUBIC BONE; RADIATION EXPOSURE; REMISSION; SACROILIITIS; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD LESION; SPONDYLOSIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; BACK PAIN; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 33845994427     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bpo.0000242438.11682.10     Document Type: Article

References (15)

1. King HA. Back pain in children. In: Weinstein SL, ed. The Pediatric Spine: Principles and Practice, 2nd ed. Philadelphia, PA: JB Lippincott Company; 2001:123-132.
2. Sty JR, Wells RG, Conway JJ. Spine pain in children. Semin Nucl Med. 1993;4:296-320.
3. Scirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med. 1999;40:1623-1629.
4. Schirrmeister H, Guhlnamm A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381-2389.
5. Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol. 1998;16:3375-3379.
6. Bockisch A, Beyer T, Antoch G, et al. Positron emission tomography/computed tomography imaging protocols, artifacts, and pitfalls. Mol Imaging Biol. 2004;6:188-199.
7. Cook JR, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer. 2000;88:2927-2933.
8. Petren-Mallmin M, Andrasson I, Ljunggren O, et al. Skeletal metastases from breast cancer: uptake of F18-fluoride measured with positron emission tomography in correlation with CT. Skeletal Radiol. 1998;27:72-76.
9. Hawkins RA, Choi Y, Huang SC, et al. Evaluation of skeletal kinetics of fluorine 18-fluoride ion and PET. J Nucl Med. 1992;33:633-642.
10. Metser U, Lerman H, Blank A, et al. Malignant involvement of the spine: assessment by 18F-FDG PET-CT. J Nucl Med. 2004;45:279-284.
11. Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med. 2004;45:272-278.
12. Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72.
13. Melzack R, Coderre TJ, Katz J, et al. Central neuroplasticity and pathological pain. Ann N Y Acad Sci. 2001;933:157-174.
14. Deleo JA. Basic science of pain. J Bone Joint Surg Am. 2006;88-A (Suppl 2):58-62.
15. Pincus T, Vlaeyen JWS, Kendall NAS, et al. Cognitive-behavioral therapy and psychosocial factors in low back pain. Directions for the future. Spine. 2002;5:E134-E138.